Notice2023-02313
National Heart, Lung, and Blood Institute Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 3, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 23 (Friday, February 3, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 23 (Friday, February 3, 2023)]
[Notices]
[Page 7449]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-02313]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Regenerative Medicine Innovation Project
Review.
Date: March 2, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Kazuyo Kegan, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
208-T, Bethesda, MD 20892, (301) 402-1334, <a href="/cdn-cgi/l/email-protection#ea818b909f9385c4818f8d8b84aa848382c48d859c"><span class="__cf_email__" data-cfemail="94fff5eee1edfbbafff1f3f5fad4fafdfcbaf3fbe2">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; K38 Review Meeting.
Date: March 3, 2023.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Kristen Page, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute National Institutes of Health, 6705 Rockledge Drive, Room
209-B, Bethesda, MD 20892, (301) 827-7953, <a href="/cdn-cgi/l/email-protection#5239203b2126373c7c22333537123c3b3a7c353d24"><span class="__cf_email__" data-cfemail="412a33283235242f6f31202624012f28296f262e37">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Regenerative Medicine Innovation Project
Investigator-Initiated Clinical Trials Grant Review.
Date: March 7, 2023.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Kazuyo Kegan, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
208-T, Bethesda, MD 20892 (301) 402-1334, <a href="/cdn-cgi/l/email-protection#96fdf7ece3eff9b8fdf3f1f7f8d6f8fffeb8f1f9e0"><span class="__cf_email__" data-cfemail="701b110a05091f5e1b1517111e301e19185e171f06">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Mentored Career Development to Promote Faculty
Diversity in Research.
Date: March 9, 2023.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Shelley Sehnert, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Suite
208-T, Bethesda, MD 20817, (301) 827-7984, <a href="/cdn-cgi/l/email-protection#e59696808d8b809791a58b8d89878ccb8b8c8dcb828a93"><span class="__cf_email__" data-cfemail="bbc8c8ded3d5dec9cffbd5d3d7d9d295d5d2d395dcd4cd">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Biorepository: Scientific Opportunities
for Exploratory Research (R21).
Date: March 10, 2023.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific Review Officer, Office
of Scientific Review/DERA, National Heart, Lung, and Blood Institute,
National Institutes of Health, 6705 Rockledge Drive, Room 208-S,
Bethesda, MD 20892, (301) 435-0270, <a href="/cdn-cgi/l/email-protection#d3a0a6bdfda0b2a1b6a793bdbabbfdb4bca5"><span class="__cf_email__" data-cfemail="fb888e95d5889a899e8fbb959293d59c948d">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Catalyze: Product Definition.
Date: March 14, 2023.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705 Rockledge
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manoj K. Valiyaveettil, Ph.D., Scientific Review
Officer, Blood & Vascular Branch, Office Scientific Review, Division of
Extramural Research Activities (DERA), National Institute of Health,
National Heart, Lung, and Blood Institute, Bethesda, MD 20817, (301)
402-1616, <a href="/cdn-cgi/l/email-protection#b7dad6d9d8dd99c1d6dbdeced6c1d2d2c3c3dedbf7d9dedf99d0d8c1"><span class="__cf_email__" data-cfemail="d7bab6b9b8bdf9a1b6bbbeaeb6a1b2b2a3a3bebb97b9bebff9b0b8a1">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI TOPMed: Omics Phenotypes of Heart, Lung,
and Blood Disorders (X01).
Date: March 16, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National, Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge Drive,
Room 208-Z, Bethesda, MD 20892, (301) 827-7987,
<a href="/cdn-cgi/l/email-protection#d8abadabb9b6f6abadb6b6b9aabab7aabf98b6b1b0f6bfb7ae"><span class="__cf_email__" data-cfemail="a8dbdddbc9c686dbddc6c6c9dacac7dacfe8c6c1c086cfc7de">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Mentored Career Development K-Awards.
Date: March 16, 2023.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Fungai Chanetsa, Ph.D., MPH, Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge Drive,
Room 206-B, Bethesda, MD 20817, (301) 402-9394,
<a href="/cdn-cgi/l/email-protection#f096859e979199de9398919e95848391b09e9998de979f86"><span class="__cf_email__" data-cfemail="82e4f7ece5e3ebace1eae3ece7f6f1e3c2ecebeaace5edf4">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National
Center for Sleep Disorders Research; 93.837, Heart and Vascular
Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood
Diseases and Resources Research, National Institutes of Health, HHS)
Dated: January 31, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-02313 Filed 2-2-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 3, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.